» Articles » PMID: 15699156

Induction of Cell Cycle Arrest in Lymphocytes by Actinobacillus Actinomycetemcomitans Cytolethal Distending Toxin Requires Three Subunits for Maximum Activity

Overview
Journal J Immunol
Date 2005 Feb 9
PMID 15699156
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

We have previously shown that Actinobacillus actinomycetemcomitans produces an immunosuppressive factor encoded by the cytolethal distending toxin (cdt)B gene. In this study, we used rCdt peptides to study the contribution of each subunit to toxin activity. As previously reported, CdtB is the only Cdt subunit that is capable of inducing cell cycle arrest by itself. Although CdtA and CdtC do not exhibit activity alone, each subunit is able to significantly enhance the ability of CdtB to induce G2 arrest in Jurkat cells; these effects were dependent upon protein concentration. Moreover, the combined addition of both CdtA and CdtC increased the ED50 for CdtB >7000-fold. In another series of experiments, we demonstrate that the three Cdt peptides are able to form a functional toxin unit on the cell surface. However, these interactions first require that a complex forms between the CdtA and CdtC subunits, indicating that these peptides are required for interaction between the cell and the holotoxin. This conclusion is further supported by experiments in which both Jurkat cells and normal human lymphocytes were protected from Cdt holotoxin-induced G2 arrest by pre-exposure to CdtA and CdtC. Finally, we have used optical biosensor technology to show that CdtA and CdtC have a strong affinity for one another (10(-7) M). Furthermore, although CdtB is unable to bind to either CdtA or CdtC alone, it is capable of forming a stable complex with CdtA/CdtC. The implications of our results with respect to the function and structure of the Cdt holotoxin are discussed.

Citing Articles

Cellugyrin (synaptogyrin-2) dependent pathways are used by bacterial cytolethal distending toxin and SARS-CoV-2 virus to gain cell entry.

Boesze-Battaglia K, Cohen G, Bates P, Walker L, Zekavat A, Shenker B Front Cell Infect Microbiol. 2024; 14:1334224.

PMID: 38698905 PMC: 11063343. DOI: 10.3389/fcimb.2024.1334224.


Cytolethal Distending Toxin Induces Cellugyrin-(Synaptogyrin 2) Dependent Cellular Senescence in Oral Keratinocytes.

Shenker B, Korostoff J, Walker L, Zekavat A, Dhingra A, Kim T Pathogens. 2024; 13(2).

PMID: 38392893 PMC: 10892517. DOI: 10.3390/pathogens13020155.


cytolethal distending toxin modulates host phagocytic function.

Kim T, Shenker B, MacElory A, Spradlin S, Walker L, Boesze-Battaglia K Front Cell Infect Microbiol. 2023; 13:1220089.

PMID: 37719670 PMC: 10500838. DOI: 10.3389/fcimb.2023.1220089.


Cytolethal Distending Toxin-Induces Cell Cycle Arrest in a Glycogen Synthase Kinase (GSK)-3-Dependent Manner in Oral Keratinocytes.

Shenker B, Walker L, Zekavat A, Korostoff J, Boesze-Battaglia K Int J Mol Sci. 2022; 23(19).

PMID: 36233133 PMC: 9570058. DOI: 10.3390/ijms231911831.


The Active Subunit of the Cytolethal Distending Toxin, CdtB, Derived From Both and Exhibits Potent Phosphatidylinositol-3,4,5-Triphosphate Phosphatase Activity.

Huang G, Boesze-Battaglia K, Walker L, Zekavat A, Schaefer Z, Blanke S Front Cell Infect Microbiol. 2021; 11:664221.

PMID: 33854985 PMC: 8039388. DOI: 10.3389/fcimb.2021.664221.